All payments made in the preview are in test mode. Read more
Sign in
Back to Atlas
APotentially durableStandard research/education caution
CMP-0126
Experimental

TB-500

Regenerative

Soft tissue recovery and repair positioning

Reading this compound Reference only
Information below is educational. Dosing, mechanisms and status fields are compiled from the source list at the bottom of this page — always verify against a licensed clinician before use.

Reference-only summary of publicly discussed or source-listed patterns. Not medical advice and not a personal recommendation.

Mechanism & Use

Compound type
Peptide fragment
Primary mechanism
Thymosin beta-4 related cell migration
Primary market use
Sports recovery

Pharmacology

Molecular weight (Da)
~4963.5
Oral bioavailability
N/A
Half-life
~2 h; not well established
Route tags
SubQ; Injectable; route-dependent
Evidence level
Preclinical
Clinical status
Experimental
Value-for-money score
7 / 10

Reported protocol signal

SQ: • 750 mcg daily for 20 days (Tailor Made Compounding Catalog) • 1 mg twice a week (World of Peptides) • 300 mcg to 1 mg daily for no longer than 3 months, followed by 1 month off (Dr. Seeds) • 450 mcg daily for 30 days (Peptide Dosing Guide) • 2.0-2.5 mg every other day (Jay Campbell)

For orientation only. See disclaimer — always consult a licensed clinician before use.

Notes

Common research-market regenerative peptide

Educational and organizational assistant matrix. Not medical advice.

BioChrysalis Atlas is an educational, organizational, and tracking asset. It does not provide medical advice, diagnosis, treatment, prescriptions, or individualized dosing instructions. Compound profiles, protocol notes, and dosage fields summarize publicly discussed or source-listed reference patterns and are not recommendations. Consult a qualified healthcare professional before starting, stopping, or modifying any compound, medication, or supplement protocol.

© BioChrysalis · Evolve · Ascend · Transcend